Exogenous Extracellular Vesicles as Emerging Platforms in Translational Medicine

Announcing a new article publication for BIO Integration journal. Extracellular vesicles (EVs) are nanoscale, membrane-bound carriers that are naturally secreted by cells and capable of transporting proteins, lipids, and nucleic acids across biological barriers. As key mediators of intercellular communication, EVs participate in immune regulation, tissue repair, and disease progression. The structural integrity of EVs, which is conferred by a lipid bilayer, protects cargo from degradation, while surface molecules facilitate targeted cell interactions. With increasing interest in their therapeutic utility, EVs have emerged as promising candidates in diagnostics, drug delivery, and regenerative medicine.

EVs derived from milk, plants, and microbes exhibit distinct bioactivities, broadening the applicability in translational research. The intrinsic biocompatibility and low immunogenicity of EVs further enhance their clinical relevance. This review highlights recent advances in the understanding and biomedical utilization of exogenous EVs. The structural features, mechanisms of cellular uptake, and functional roles in modulating disease pathways are discussed. Furthermore, the unique advantages and challenges of leveraging exogenous EVs for clinical translation are explored, including standardization, loading efficiency, and targeting specificity. With continuous innovation at the interface of nanotechnology, synthetic biology, and biomedicine, exogenous EVs are poised to become next-generation platforms for precision therapy and regenerative strategies.

Read More: https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0122

BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

Please visit www.bio-integration.org to learn more about the journal.

Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available on the ScienceOpen platform (https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781).

Submissions may be made using ScholarOne (https://mc04.manuscriptcentral.com/bioi).

There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio; Facebook (https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and LinkedIn (https://www.linkedin.com/company/bio-integration-journal/).

ISSN 2712-0074

eISSN 2712-0082 Muran Bai, Zhongshi Li and Tianren Shi et al. Exogenous Extracellular Vesicles as Emerging Platforms in Translational Medicine. BIOI. 2025. Vol. 6(1). DOI: 10.15212/bioi-2025-0122